National Healthcare Properties (HLTC) AI Stock Analysis

• Market Cap: $217.31M
• Dividend Yield: N/A
• Average Volume (3M): 184.00
• Price to Earnings (P/E): ―
• Beta (1Y): -2.04
• Revenue Growth: -0.99%
• EPS Growth: 49.89%
• Country: US
• Employees: 26
• Sector: Real Estate
• Sector Strength: 53
• Industry: REIT - Healthcare Facilities
• EPS (TTM): -0.18
• Shares Outstanding: 28,296,438
• 10 Day Avg. Volume: 152
• 30 Day Avg. Volume: 184
• PEG Ratio: >-0.01
• Price to Book (P/B): 0.33
• Price to Sales (P/S): 0.64
• P/FCF Ratio: -2.23
• Enterprise Value/Market Cap: 5.47
• Enterprise Value/Revenue: 3.41
• Enterprise Value/Gross Profit: 9.42
• Enterprise Value/Ebitda: 18.66
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 44 Neutral
• Price Target: $7.50 ▼(-12.28% Downside)

The overall stock score is primarily impacted by the company's weak financial performance, characterized by declining revenues, high leverage, and negative cash flows. While there is some positive short-term technical momentum, the overbought RSI suggests caution. The valuation is unattractive due to a negative P/E ratio and lack of dividends, further weighing down the score.

National Healthcare Properties Business Overview & Revenue Model

Company Description

National Healthcare Properties (HLTC) is a real estate investment trust (REIT) that focuses on acquiring, owning, and managing healthcare-related properties across the United States. The company primarily operates in sectors such as senior housing, skilled nursing facilities, and medical office buildings. HLTC provides essential real estate services that support healthcare providers, ensuring that they have the facilities needed to deliver quality care to their patients.

How the Company Makes Money

National Healthcare Properties generates revenue primarily through leasing its properties to healthcare operators under long-term agreements. The company earns rental income from these leases, which typically include provisions for rent escalations tied to inflation or other economic indicators. Additionally, HLTC may benefit from property appreciation over time, enhancing its asset value. The company may also engage in strategic partnerships with healthcare operators, such as management agreements or joint ventures, which can provide additional revenue streams through profit-sharing arrangements. Factors contributing to its earnings include the growing demand for healthcare services driven by an aging population, the stability of long-term lease agreements, and the diversification of its property portfolio across various healthcare sectors.

National Healthcare Properties Financial Statement Overview

Summary

National Healthcare Properties is facing financial difficulties, with declining revenues and persistent losses impacting profitability. The high leverage and negative cash flows present significant risks. The company needs to focus on improving operational efficiency and cash flow management to stabilize its financial position.

Income Statement

National Healthcare Properties has experienced declining revenue growth, with a negative growth rate of -0.99% in the TTM period. The company is facing profitability challenges, as evidenced by negative net profit margins and EBIT margins. The gross profit margin has been relatively stable but insufficient to cover operating expenses, leading to negative net income.

Balance Sheet

The company has a high debt-to-equity ratio, indicating significant leverage, which poses a risk in a rising interest rate environment. The return on equity is negative, reflecting ongoing losses. However, the equity ratio is relatively stable, suggesting some balance sheet resilience.

Cash Flow

Cash flow from operations is negative, and free cash flow has deteriorated significantly, with a negative growth rate of -76.4% in the TTM period. The operating cash flow to net income ratio is unfavorable, indicating cash flow challenges. The company needs to improve its cash generation to support operations and debt obligations.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	348.41M	353.79M	345.93M	335.85M	329.36M	381.61M
Gross Profit	126.07M	132.65M	128.13M	122.40M	123.54M	138.06M
EBITDA	63.67M	-22.36M	76.87M	54.38M	42.59M	61.12M
Net Income	-80.05M	-189.70M	-72.30M	-79.62M	-85.18M	-75.81M
Balance Sheet
Total Assets	1.76B	1.95B	2.15B	2.18B	2.21B	2.29B
Cash, Cash Equivalents and Short-Term Investments	47.12M	21.65M	46.41M	53.65M	59.74M	72.36M
Total Debt	1.04B	1.15B	1.18B	1.12B	1.09B	1.23B
Total Liabilities	1.11B	1.26B	1.24B	1.18B	1.17B	1.33B
Stockholders Equity	647.03M	684.56M	894.15M	992.64M	1.03B	956.99M
Cash Flow
Free Cash Flow	-125.07M	-101.75M	-773.00K	302.00K	19.81M	19.91M
Operating Cash Flow	-101.96M	-79.85M	21.62M	28.30M	38.88M	41.81M
Investing Cash Flow	155.69M	63.97M	-62.82M	-41.78M	-47.92M	-82.49M
Financing Cash Flow	-31.54M	-1.35M	55.97M	4.64M	4.08M	19.43M

National Healthcare Properties Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 8.55
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HLTC, the sentiment is Positive. The current price of 8.55 is above the 20-day moving average (MA) of 7.87, above the 50-day MA of 7.66, and above the 200-day MA of 7.73, indicating a bullish trend. The MACD of 0.08 indicates Negative momentum. The RSI at 83.13 is Negative, neither overbought nor oversold. The STOCH value of 77.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HLTC.

National Healthcare Properties Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
STRW	―	$151.88M	19.43	51.91%	5.11%	24.72%	30.05%
Sector *	―	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%
GMRE	―	$620.09M	95.54	1.94%	8.61%	0.90%	―
UHT	―	$505.16M	28.13	10.08%	8.09%	0.14%	-0.76%
DHC	―	$1.04B	―	-14.32%	0.97%	4.29%	18.89%
CHCT	―	$413.87M	―	-2.22%	12.85%	2.96%	-877.53%
HLTC	―	$217.31M	―	-11.41%	―	-0.99%	49.89%